Sequence homology and structural analysis of the clostridial neurotoxins, Journal of Molecular Biology, vol.291, issue.5, pp.1091-104, 1999. ,
DOI : 10.1006/jmbi.1999.2945
Botulinum Toxin as a Biological Weapon, JAMA, vol.285, issue.8, pp.1059-70, 2001. ,
DOI : 10.1001/jama.285.8.1059
Bacterial toxins: a table of lethal amounts, Microbiol Rev, vol.46, pp.86-94, 1982. ,
Properties and use of botulinum toxin and other microbial neurotoxins in medicine, Microbiol Rev, vol.56, pp.80-99, 1992. ,
Mechanism of action of tetanus and botulinum neurotoxins, Molecular Microbiology, vol.263, issue.1, pp.1-8, 1994. ,
DOI : 10.1111/j.1432-1033.1986.tb09412.x
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2958.1994.tb00396.x
Botulinum Neurotoxin Vaccines:?? Past history and recent developments, Human Vaccines, vol.5, issue.12, pp.794-805, 2009. ,
DOI : 10.4161/hv.9420
URL : http://www.tandfonline.com/doi/pdf/10.4161/hv.9420?needAccess=true
Botulism and vaccines for its prevention, Vaccine, vol.27, issue.4, pp.33-42, 2009. ,
DOI : 10.1016/j.vaccine.2009.08.059
New and emerging indications of botulinum toxin therapy, Parkinsonism & Related Disorders, vol.17, issue.1, pp.25-32, 2011. ,
DOI : 10.1016/j.parkreldis.2011.06.017
Efficacy of Prophylactic and Therapeutic Administration of Antitoxin for Inhalation Botulism, In: Botulinum Tetanus Neurotoxins Biomed Asp, 1993. ,
DOI : 10.1007/978-1-4757-9542-4_52
Human Botulism Immune Globulin for the Treatment of Infant Botulism, New England Journal of Medicine, vol.354, issue.5, pp.462-71, 2006. ,
DOI : 10.1056/NEJMoa051926
Hypersensitivity reactions associated with botulinal antitoxin, The American Journal of Medicine, vol.69, issue.4, pp.567-70, 1980. ,
DOI : 10.1016/0002-9343(80)90469-6
, and Fab Botulinum Antitoxins in Mice, Immunopharmacology and Immunotoxicology, vol.150, issue.3, pp.397-408, 2003. ,
DOI : 10.1093/infdis/150.3.407
Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries, Vaccine, vol.20, issue.11-12, pp.1640-1648, 2002. ,
DOI : 10.1016/S0264-410X(01)00482-0
Hamid M: scFv antibody: principles and clinical application, Clin Dev Immunol, vol.2012, p.980250, 2012. ,
DOI : 10.1155/2012/980250
URL : http://doi.org/10.1155/2012/980250
Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain, PLoS ONE, vol.304, issue.8, p.3023, 2008. ,
DOI : 10.1371/journal.pone.0003023.t002
Isolation of Antibodies From Non-Human Primates for Clinical Use, Current Drug Discovery Technologies, vol.11, issue.1, pp.20-27, 2014. ,
DOI : 10.2174/15701638113109990030
Development of Anti-Toxins Antibodies for Biodefense, Journal of Bioterrorism & Biodefense, vol.2, p.1, 2011. ,
DOI : 10.4172/2157-2526.S2-005
Selection of a Macaque Fab with Framework Regions Like Those in Humans, High Affinity, and Ability To Neutralize the Protective Antigen (PA) of Bacillus anthracis by Binding to the Segment of PA between Residues 686 and 694, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3414-3434, 2005. ,
DOI : 10.1128/AAC.49.8.3414-3420.2005
Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo, PLoS ONE, vol.384, issue.4, p.37242, 2012. ,
DOI : 10.1371/journal.pone.0037242.g005
High-Affinity, Human Antibody-Like Antibody Fragment (Single-Chain Variable Fragment) Neutralizing the Lethal Factor (LF) of Bacillus anthracis by Inhibiting Protective Antigen-LF Complex Formation, Antimicrobial Agents and Chemotherapy, vol.51, issue.8, pp.2758-64, 2007. ,
DOI : 10.1128/AAC.01528-06
URL : http://aac.asm.org/content/51/8/2758.full.pdf
Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity, BMC Biotechnology, vol.9, issue.1, p.60, 2009. ,
DOI : 10.1186/1472-6750-9-60
URL : https://hal.archives-ouvertes.fr/hal-00410069
Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin, BMC Biotechnology, vol.11, issue.1, p.113, 2011. ,
DOI : 10.1186/1472-6750-11-113
Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library, mAbs, vol.57, issue.2, pp.446-59, 2014. ,
DOI : 10.1038/2338
URL : http://www.tandfonline.com/doi/pdf/10.4161/mabs.27773?needAccess=true
Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus, PLoS ONE, vol.202, issue.8, p.6625, 2009. ,
DOI : 10.1371/journal.pone.0006625.t003
A human scFv antibody generation pipeline for proteome research, Journal of Biotechnology, vol.152, issue.4, pp.159-70, 2011. ,
DOI : 10.1016/j.jbiotec.2010.09.945
Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV), BMC Biotechnology, vol.8, issue.1, p.66, 2008. ,
DOI : 10.1186/1472-6750-8-66
Germline Humanization of a Non-human Primate Antibody that Neutralizes the Anthrax Toxin, by in Vitro and in Silico Engineering, Journal of Molecular Biology, vol.384, issue.5, pp.1400-1407, 2008. ,
DOI : 10.1016/j.jmb.2008.10.033
URL : https://hal.archives-ouvertes.fr/hal-00345933
The Humanness of Macaque Antibody Sequences, Journal of Molecular Biology, vol.396, issue.5, pp.1439-50, 2010. ,
DOI : 10.1016/j.jmb.2009.12.041
URL : http://acrmwww.biochem.ucl.ac.uk/publications/freepdf/macaque_submit.pdf
Extraction and Inhibition of Enzymatic Activity of Botulinum Neurotoxins/A1, /A2, and /A3 by a Panel of Monoclonal Anti-BoNT/A Antibodies, PLoS ONE, vol.5, issue.10, p.5355, 2009. ,
DOI : 10.1371/journal.pone.0005355.t003
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody, Proceedings of the National Academy of Sciences, vol.287, issue.5458, pp.11346-50, 2002. ,
DOI : 10.1126/science.287.5458.1664
URL : http://www.pnas.org/content/99/17/11346.full.pdf
Antibody Protection against Botulinum Neurotoxin Intoxication in Mice, Infection and Immunity, vol.77, issue.10, pp.4305-4318, 2009. ,
DOI : 10.1128/IAI.00405-09
URL : http://iai.asm.org/content/77/10/4305.full.pdf
Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents, PLoS ONE, vol.5, issue.1, p.8818, 2010. ,
DOI : 10.1371/journal.pone.0008818.s003
URL : http://doi.org/10.1371/journal.pone.0008818
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A, Molecular Immunology, vol.44, issue.5, pp.1029-1070, 2007. ,
DOI : 10.1016/j.molimm.2006.03.011
Genetic Diversity among Botulinum Neurotoxin-Producing Clostridial Strains, Journal of Bacteriology, vol.189, issue.3, pp.818-850, 2007. ,
DOI : 10.1128/JB.01180-06
URL : http://jb.asm.org/content/189/3/818.full.pdf
Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum, BMC Genomics, vol.10, issue.1, p.115, 2009. ,
DOI : 10.1186/1471-2164-10-115
URL : https://bmcgenomics.biomedcentral.com/track/pdf/10.1186/1471-2164-10-115?site=bmcgenomics.biomedcentral.com
Production of single chain fragment variable (scFv) antibodies in Escherichia coli using the LEX??? bioreactor, Journal of Biotechnology, vol.163, issue.2, pp.105-116, 2013. ,
DOI : 10.1016/j.jbiotec.2012.07.011
Phrenic nerve-hemidiaphragm as a highly sensitive replacement assay for determination of functional botulinum toxin antibodies, Toxicon, vol.57, issue.7-8, pp.1008-1024, 2011. ,
DOI : 10.1016/j.toxicon.2011.04.003
Improvement of an Antibody Neutralizing the Anthrax Toxin by Simultaneous Mutagenesis of Its Six Hypervariable Loops, Journal of Molecular Biology, vol.378, issue.5, pp.1094-103, 2008. ,
DOI : 10.1016/j.jmb.2008.03.045
Guide for the Care; Use of Laboratory Animals, 2011. ,
Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies, FEBS Letters, vol.23, issue.1-3, pp.299-306, 2004. ,
DOI : 10.1023/B:JOPC.0000016257.91979.06
Obtention and Engineering of Non-Human Primate (NHP) Antibodies for Therapeutics, Mini-Reviews in Medicinal Chemistry, vol.9, issue.14, pp.1633-1641, 2009. ,
DOI : 10.2174/138955709791012283
Construction of Human Antibody Gene Libraries and Selection of Antibodies by Phage Display, Methods Mol Biol, vol.1060, pp.215-258, 2014. ,
DOI : 10.1007/978-1-62703-586-6_12
Analysis of Mass Transport-Limited Binding Kinetics in Evanescent Wave Biosensors, Analytical Biochemistry, vol.240, issue.2, pp.262-72, 1996. ,
DOI : 10.1006/abio.1996.0356
HighV-QUEST: the IMGT® web portal for immunoglobulin (IG) or antibody and T cell receptor (TR) analysis from NGS high throughput and deep sequencing, Immunome Res, vol.8, p.26, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00722909
IMGT/DomainGapAlign: The IMGT?? Tool for the Analysis of IG, TR, MH, IgSF, and MhSF Domain Amino Acid Polymorphism, Methods Mol Biol, vol.882, pp.605-638, 2012. ,
DOI : 10.1007/978-1-61779-842-9_33
URL : https://hal.archives-ouvertes.fr/hal-00722914
Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve???hemidiaphragm: Improved precision with in-bred mice, Toxicon, vol.53, issue.5, pp.503-514, 2009. ,
DOI : 10.1016/j.toxicon.2009.01.019